Cancundude/iconoclast - There may be an instance where both of you are correct in our situation. If the FDA meeting comes after 16 Nov and there is an offer made to acquire RVX in-between then and the meeting with the FDA but based on successful outcome of said meeting then everyone wins, RVX, the BP that made the offer, the FDA and most of all the patients that could use a safe drug to cure or ease an ailment that currently does not have an alternative drug available. If that happens to be the cognitive issue that I outlined the other day the annual savings to governments, insurers and the families of those patients could be massive. Win win business transactions are always great ideas, in this case it's a win, win, win, win opportunity.

Actually, it doesn’t even have to wait until after 16 Nov. An offer and an FDA meeting could happen anytime as all parties could do this meeting under CA’s.

Just a thought.

tada